Deubiquitination of γ-tubulin by BAP1 prevents chromosome instability in breast cancer cells

Cancer Research

Volumn 74, Issue 22, 2014, Pages 6499-6508

  Zarrizi, Reihaneh ^a   Menard, Julien Albert ^a   Belting, Mattias ^a,b   Massoumi, Ramin ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; GAMMA TUBULIN; BAP1 PROTEIN, HUMAN; TUBULIN; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN THIOLESTERASE;

ARTICLE; BAP1 GENE; BREAST ADENOCARCINOMA; BREAST CANCER CELL LINE; BREAST METASTASIS; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; DEUBIQUITINATION; DOWN REGULATION; EPITHELIUM CELL; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOSIS SPINDLE; ONCOGENE; OVERALL SURVIVAL; PROTEIN MODIFICATION; CELL CYCLE; CHROMOSOME ABERRATION; FEMALE; METABOLISM; PHYSIOLOGY; SPINDLE APPARATUS; TUMOR CELL LINE; UBIQUITINATION;

CELL CYCLE; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; FEMALE; HUMANS; SPINDLE APPARATUS; TUBULIN; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE; UBIQUITINATION;

EID: 84918499999     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-0221     Document Type: Article

References (29)

1. Pickart CM. Mechanisms underlying ubiquitination. Annu Rev Biochem 2001;70:503-33.
2. Weissman AM Themes and variations on ubiquitylation. Nature Rev Mol Cell Biol 2001;2:169-78.
3. Massoumi R Ubiquitin chain cleavage: CYLD at work. Trends Biochem Sci 2010;35:392-9.
4. Nijman S, Luna-Vargas M, Velds A, Brummelkamp TR, Dirac AM, Sixma TK, et al. A genomic and functional inventory of deubiquitinating enzymes. Cell 2005;123:773-86.
5. Jensen DE, Proctor M, Marquis ST, Gardner HP, Ha SI, Chodosh LA, et al. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression. Oncogene 1998;16:1097-112.
6. Ventii KH, Devi NS, Friedrich KL, Chernova TA, Tighiouart M, Van Meir EG, et al. BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization. Cancer Res 2008;68:6953-62.
7. Harbour JW, Onken MD, Roberson ED, Duan S, Cao L, Worley LA, et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 2010;330:1410-3.
8. Eletr ZM, Wilkinson KD. An emerging model for BAP1's role in regulating cell cycle progression. Cell Biochem Biophys 2011;60:3-11.
9. Mallery DL, Vandenberg CJ, Hiom K. Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains. EMBO J 2002;21:6755-62.
10. Nishikawa H, Wu W, Koike A, Kojima R, Gomi H, Fukuda M, et al. BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity. Cancer Res 2009;69:111-9.
11. Dey A, Seshasayee D, Noubade R, French DM, Liu J, Chaurushiya MS, et al. Loss of the tumor suppressor BAP1 causes myeloid transformation. Science 2012;337:1541-6.
12. Kollman JM, Merdes A, Mourey L, Agard DA. Microtubule nucleation by g-tubulin complexes. Nature Rev Mol Cell Biol 2011;12:709-21.
13. Sankaran S, Starita LM, Groen AC, Ko MJ, Parvin JD. Centrosomal microtubule nucleation activity is inhibited by BRCA1-dependent ubiquitination. Mol Cell Biol 2005;25:8656-68.
14. Sankaran S, Crone DE, Palazzo RE, Parvin JD. BRCA1 regulates g-tubulin binding to centrosomes. Cancer Biol Ther 2007;6:1853-7.
15. Starita LM, Machida Y, Sankaran S, Elias JE, Griffin K, Schlegel BP, et al. BRCA1-dependent ubiquitination of g-tubulin regulates centrosome number. Mol Cell Biol 2004;24:8457-66.
16. Parvin JD. The BRCA1-dependent ubiquitin ligase, g-tubulin, and centrosomes. Environ Mol Mutagen 2009;50:649-53.
17. Hsu LC, White RL. BRCA1 is associated with the centrosome during mitosis. Proc Natl Acad Sci U S A 1998;95:12983-8.
18. Lotti LV, Ottini L, D'Amico C, Gradini R, Cama A, Belleudi F, et al. Subcellular localization of the BRCA1 gene product in mitotic cells. Genes Chromosomes Cancer 2002;35:193-203.
19. Sankaran S, Starita LM, Simons AM, Parvin JD. Identification of domains of BRCA1 critical for the ubiquitin-dependent inhibition of centrosome function. Cancer Res 2006;66:4100-7.
20. Xu X, Weaver Z, Linke SP, Li C, Gotay J, Wang XW, et al. Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol Cell 1999;3:389-95.
21. Testa JR, Cheung M, Pei J, Below JE, Tan Y, Sementino E, et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nat Genet 2011;43:1022-5.
22. Bott M, Brevet M, Taylor BS, Shimizu S, Ito T, Wang L, et al. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat Genet 2011;43:668-72.
23. Wiesner T, Obenauf AC, Murali R, Fried I, Griewank KG, Ulz P, et al. Germline mutations in BAP1 predispose to melanocytic tumors. Nat Genet 2011;43:1018-21.
24. Abdel-Rahman MH, Pilarski R, Cebulla CM, Massengill JB, Christopher BN, Boru G, et al. Germline BAP1 mutation predisposes to uveal melanoma, lung adenocarcinoma, meningioma, and other cancers. J Med Genet 2011;48:856-9.
25. Fan LH, Tang LN, Yue L, Yang Y, Gao ZL, Shen Z. BAP1 is a good prognostic factor in advanced non-small cell lung cancer. Clin Invest Med 2012;35:E182-9.
26. Pena-Llopis S, Vega-Rubin-De-Celis S, Liao A, Leng N, Pavia-Jimenez A, Wang S, et al. BAP1 loss defines a new class of renal cell carcinoma. Nat Genet 2012;44:751-9.
27. Piehl M, Tulu US, Wadsworth P, Cassimeris L. Centrosome maturation: measurement of microtubule nucleation throughout the cell cycle by using GFP-tagged EB1. Proc Natl Acad SciUSA 2004;101:1584-8.
28. Khodjakov A, Rieder CL. The sudden recruitment of g-tubulin to the centrosome at the onset of mitosis and its dynamic exchange throughout the cell cycle, do not require microtubules. J Cell Biol 1999;146:585-96.
29. Kuriyama R, Borisy GG. Microtubule-nucleating activity of centrosomes in Chinese hamster ovary cells is independent of the centriole cycle but coupled to the mitotic cycle. J Cell Biol 1981;91:822-6.